Top Sell
| Security | Buy | Sell ▼ | Buy (1M) | Sell (1M) | Price | Target price | Potential |
|---|---|---|---|---|---|---|---|
| Evoke Pharma Inc. | 0 | 24 | 0 | 1 | €0.38 | - | - |
| Moleculin Biotech Inc | 3 | 23 | 0 | 1 | €0.41 | €18.42 | 4393.659% |
| Trevena Inc. | 2 | 21 | 0 | 2 | €0.16 | €6.48 | 3906.180% |
| Arca Biopharma | 0 | 17 | 0 | 1 | €2.86 | - | - |
| InVivo Therapeutics Holdings | 0 | 15 | 0 | 0 | €0.31 | - | - |
| Bellicum Pharmaceuticals Inc. | 0 | 12 | 0 | 0 | €0.064 | - | - |
| Mirati Therapeutics Inc. | 2 | 10 | 0 | 0 | €53.84 | €78.43 | 45.666% |
| Cyclacel Pharmaceuticals Inc. | 2 | 10 | 0 | 0 | €0.22 | €14.66 | 6565.591% |
| Minerva Neurosciences Inc. | 0 | 9 | 0 | 3 | €2.76 | - | - |
| Organovo Holdings Inc. | 0 | 8 | 0 | 1 | €0.48 | - | - |
| Waters Corp. | 0 | 6 | 0 | 1 | €316.70 | €265.52 | -16.160% |
| T2 Biosystems Inc. | 0 | 6 | 0 | 0 | €0.16 | - | - |
| Cellectar BioSciences Inc. | 5 | 6 | 1 | 0 | €1.66 | €11.09 | 568.169% |
| Bluebird Bio Inc. | 4 | 6 | 0 | 0 | €0.95 | €6.49 | 582.541% |
| Pacific Biosciences of California Inc. | 9 | 5 | 0 | 0 | €1.39 | €9.62 | 593.649% |
| Sage Therapeutics Inc. | 8 | 4 | 1 | 0 | €8.57 | €25.88 | 202.026% |
| Cara Therapeutics Inc. | 11 | 4 | 0 | 1 | €0.31 | €4.62 | 1370.719% |
| Cardiff Oncology Inc. | 2 | 4 | 0 | 0 | €2.04 | €5.00 | 145.098% |
| Integra LifeSciences Holdings Corp | 3 | 4 | 0 | 1 | €21.80 | €24.77 | 13.623% |
| Palatin Technologies Inc. | 0 | 4 | 0 | 0 | €1.46 | - | - |
| Larimar Therapeutics Inc. | 2 | 3 | 0 | 0 | €7.25 | €110.00 | 1417.241% |
| Atara Biotherapeutics Inc. | 2 | 3 | 0 | 0 | €0.37 | €3.00 | 716.549% |
| Avinger Inc. | 2 | 3 | 0 | 0 | €0.34 | €4.64 | 1272.633% |
| Elanco Animal Health Inc. | 8 | 3 | 0 | 0 | €10.91 | €16.17 | 48.155% |
| Nevro Corp. | 2 | 3 | 0 | 1 | €8.20 | €14.72 | 79.517% |